Involvement of Spinal Serotonin Receptors in Electroacupuncture Anti-hyperalgesia in an Inflammatory Pain Rat Model
Overview
Affiliations
We previously showed that electroacupuncture (EA) activates medulla-spinal serotonin-containing neurons. The present study investigated the effects of intrathecal 5,7-dihydroxytryptamine creatinine sulfate, a selective neurotoxin for serotonergic terminals, the 5-hydroxytryptamine 1A receptor (5-HT1AR) antagonist NAN-190 hydrobromide and the 5-HT2C receptor (5-HT2CR) antagonist SB-242,084 on EA anti-hyperalgesia. EA was given twice at acupoint GB30 after complete Freund's adjuvant (CFA) injection into hind paw. CFA-induced hyperalgesia was measured by assessing hind paw withdrawal latency (PWL) to a noxious thermal stimulus 30 min post-EA. Serotonin depletion and the 5-HT1AR antagonist blocked EA anti-hyperalgesia; the 5-HT2CR antagonist did not. Immunohistochemical staining showed that spinal 5-HT1AR was expressed and that 5-HT2CR was absent in naive and CFA-injected animals 2.5 h post-CFA. These results show a correlation between EA anti-hyperalgesia and receptor expression. Collectively, the data show that EA activates supraspinal serotonin neurons to release 5-HT, which acts on spinal 5-HT1AR to inhibit hyperalgesia.
Khan K, Bierlein-De La Rosa G, Biggerstaff N, Selvakumar G, Wang R, Mason S Brain Behav Immun. 2022; 107:419-431.
PMID: 35907582 PMC: 10289137. DOI: 10.1016/j.bbi.2022.07.160.
Sun R, Li S, Ren L, Xia Y, Wang Y, Bian Z J Pain Res. 2022; 15:959-968.
PMID: 35411183 PMC: 8994622. DOI: 10.2147/JPR.S357435.
Dou B, Li Y, Ma J, Xu Z, Fan W, Tian L Front Neurosci. 2021; 15:695670.
PMID: 34408622 PMC: 8366064. DOI: 10.3389/fnins.2021.695670.
Lyu Z, Guo Y, Gong Y, Fan W, Dou B, Li N Neural Plast. 2021; 2021:8881557.
PMID: 33531894 PMC: 7834789. DOI: 10.1155/2021/8881557.
The Involvement of Descending Pain Inhibitory System in Electroacupuncture-Induced Analgesia.
Lv Q, Wu F, Gan X, Yang X, Zhou L, Chen J Front Integr Neurosci. 2019; 13:38.
PMID: 31496944 PMC: 6712431. DOI: 10.3389/fnint.2019.00038.